Contributions
Abstract: PB2226
Type: Publication Only
Background
Multiple myeloma is a chronic pathology diagnosed usually in elderly patients. It often presents with systemic involvement (bone lesions, renal failure, anemia, infections) secondary to the pathology itself or as a treatment side effect.
Patients often come to consult or the emergency department spotaneously for problems arising from this pathology.
Thanks to the collaboration of Celgene we have developed a link project in our center, whereby a case management hematologist through a telematic medical consultation (telephone and via email), detects side effects of treatment, prescribes complementary tests or modifies adjuvant treatment and derives early to other specialists in the cases that it is necessary.
With this, diagnostic and therapeutic delays have been avoided in patients affected by Multiple Myeloma, improving their quality of life and strengthening the doctor-patient relationship.
Aims
We summarize the activity of the first year of implementation of the telematic consultation and the benefits obtained from it.
Methods
In March 2017, the project was initiated and presented personally to each patient with multiple myeloma. In our center we have 104 patients in follow-up in this period of time, of which 80% have been included in the project for the time being.
Results
51 patients have attended at least one telematic consultation (median 2, range 1-21). Tables 1 and 2 summarize the type of activity attended. We have save more than 135 spontaneous visits of the patients to our consultations or emergencies. We have also reduced the time until resolution of the reason for consultation. More detail information will be provided in the congress.
Conclusion
The telematic consultation can save hospital visits, reduce attention time, and improve the monitoring and quality of life of our patients.
In an increasingly technological society, the incorporation of mobile phone, email and other tools will be more common in our clinical practice.
Session topic: 14. Myeloma and other monoclonal gammopathies - Clinical
Keyword(s): Follow-up, Health care, Multiple Myeloma, Patient
Abstract: PB2226
Type: Publication Only
Background
Multiple myeloma is a chronic pathology diagnosed usually in elderly patients. It often presents with systemic involvement (bone lesions, renal failure, anemia, infections) secondary to the pathology itself or as a treatment side effect.
Patients often come to consult or the emergency department spotaneously for problems arising from this pathology.
Thanks to the collaboration of Celgene we have developed a link project in our center, whereby a case management hematologist through a telematic medical consultation (telephone and via email), detects side effects of treatment, prescribes complementary tests or modifies adjuvant treatment and derives early to other specialists in the cases that it is necessary.
With this, diagnostic and therapeutic delays have been avoided in patients affected by Multiple Myeloma, improving their quality of life and strengthening the doctor-patient relationship.
Aims
We summarize the activity of the first year of implementation of the telematic consultation and the benefits obtained from it.
Methods
In March 2017, the project was initiated and presented personally to each patient with multiple myeloma. In our center we have 104 patients in follow-up in this period of time, of which 80% have been included in the project for the time being.
Results
51 patients have attended at least one telematic consultation (median 2, range 1-21). Tables 1 and 2 summarize the type of activity attended. We have save more than 135 spontaneous visits of the patients to our consultations or emergencies. We have also reduced the time until resolution of the reason for consultation. More detail information will be provided in the congress.
Conclusion
The telematic consultation can save hospital visits, reduce attention time, and improve the monitoring and quality of life of our patients.
In an increasingly technological society, the incorporation of mobile phone, email and other tools will be more common in our clinical practice.
Session topic: 14. Myeloma and other monoclonal gammopathies - Clinical
Keyword(s): Follow-up, Health care, Multiple Myeloma, Patient